NNNN (Anbio Biotechnology) Median PS Value: $0.00 (As of Jul. 04, 2026)


NNNN Anbio Biotechnology NNNN
24 GF Score
Price $12.46
! 2 Warning Signs
View Full Analysis

What is Anbio Biotechnology Median PS Value?

Anbio Biotechnology NNNN +2.88% 24 Median PS Value is $0.00 as of Jul. 04, 2026. GuruFocus rates NNNN with a GF Score™ of 24/100. The stock has 2 warning signs investors should review. Among 337 Medical Devices & Instruments companies, Anbio Biotechnology ranks worse than 296735.61% on this metric.

This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Anbio Biotechnology's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $0.199. Anbio Biotechnology's 10-Year median PS Ratio is 0. Therefore, the Median PS Value for today is $0.00.

As of today (2026-07-04), Anbio Biotechnology's share price is $12.46. Anbio Biotechnology's Median PS Value is $0.00. Therefore, Anbio Biotechnology's Price to Median PS Value for today is 0.00.

The historical rank and industry rank for Anbio Biotechnology's Median PS Value or its related term are showing as below:

NNNN's Price-to-Median-PS-Value is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 0.72
* Ranked among companies with meaningful Price-to-Median-PS-Value only.

Anbio Biotechnology  (NAS:NNNN) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

Anbio Biotechnology's Price to Median PS Value for today is calculated as

Price to Median PS Value=Share Price/Median PS Value
=12.46/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Anbio Biotechnology Median PS Value Related Terms


Anbio Biotechnology Median PS Value Historical Data

* Premium members only.

The historical data trend for Anbio Biotechnology's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Anbio Biotechnology Median PS Value Chart

Anbio Biotechnology Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Median PS Value
0.00 0.00 0.00 0.00 0.00

Anbio Biotechnology Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Median PS Value Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00

NNNN vs ANGO, OSUR, UTMD: Median PS Value Comparison

For the Medical Instruments & Supplies subindustry, Anbio Biotechnology's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Anbio Biotechnology Price-to-Median-PS-Value vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Anbio Biotechnology's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where Anbio Biotechnology's Price-to-Median-PS-Value falls into.


NNNN
24GF Score
Anbio Biotechnology NNNN
Median PS Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Anbio Biotechnology Median PS Value Calculation

Anbio Biotechnology's Median PS Value for today is calculated as

Median PS Value=Revenue per Share (TTM)*10-Year Median PS Ratio
=0.199*0
=0.00

10-Year Median PS Ratio is 0.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Anbio Biotechnology's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $0.199.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Median PS Value →
What does a Median PS Value of $0.00 mean?
Anbio Biotechnology (NNNN) has a Median PS Value of $0.00 as of Jul. 04, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Anbio Biotechnology and its competitors. According to the industry distribution chart, Anbio Biotechnology ranks #999999 out of 337 companies in the Medical Devices & Instruments industry.
Is Anbio Biotechnology's Median PS Value too high?
Anbio Biotechnology's current Median PS Value is $0.00. Based on the distribution chart, Anbio Biotechnology ranks #999999 out of 337 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Anbio Biotechnology has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does Anbio Biotechnology's Median PS Value compare to ANGO and OSUR?
According to the Medical Devices & Instruments industry distribution chart, Anbio Biotechnology ranks #999999 out of 337 companies for Median PS Value. This places Anbio Biotechnology in the lower half of its industry. The industry median Median PS Value is 0.72. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Medical Devices & Instruments company?
The median Median PS Value among Medical Devices & Instruments companies is 0.72, based on 337 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Anbio Biotechnology and its competitors. For the Medical Devices & Instruments industry, the median Median PS Value is 0.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Anbio Biotechnology's current Median PS Value is $0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Anbio Biotechnology stock overvalued right now?
Anbio Biotechnology (NNNN) has a current Median PS Value of $0.00. The current Median PS Value is $0.00. Anbio Biotechnology's overall GF Score™ is 24/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Anbio Biotechnology (NNNN), the current Median PS Value is $0.00 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Anbio Biotechnology Business Description

Address Friedrich-Ebert-Anlage 35-37, Frankfurt am Main, HE, DEU, 60327
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR).
24GF Score

Get the complete analysis for NNNN

Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$12.46
Price